BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sorenson CM, Barry MA, Eastman A. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst. 1990;82:749-755. [PMID: 1691303 DOI: 10.1093/jnci/82.9.749] [Cited by in Crossref: 289] [Cited by in F6Publishing: 302] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Moufarij MA, Phillips DR, Cullinane C. Gemcitabine potentiates cisplatin cytotoxicity and inhibits repair of cisplatin-DNA damage in ovarian cancer cell lines. Mol Pharmacol. 2003;63:862-869. [PMID: 12644587 DOI: 10.1124/mol.63.4.862] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 3.1] [Reference Citation Analysis]
2 Xiao-ming S, Snowden RT, Dinsdale D, Ormerod MG, Cohen GM. Changes in nuclear chromatin precede internucleosomal DNA cleavage in the induction of apoptosis by etoposide. Biochemical Pharmacology 1994;47:187-95. [DOI: 10.1016/0006-2952(94)90005-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 0.5] [Reference Citation Analysis]
3 Lo Nigro C, Arnolfo E, Taricco E, Fruttero A, Russi EG, Lucio F, Ribero S, Comino A, Merlano M, Ungari S. The cisplatin-irradiation combination suggests that apoptosis is not a major determinant of clonogenic death. Anticancer Drugs 2007;18:659-67. [PMID: 17762394 DOI: 10.1097/CAD.0b013e328087388f] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Subramanian T, Tarodi B, Govindarajan R, Boyd JM, Yoshida K, Chinnadurai G. Mutational analysis of the transforming and apoptosis suppression activities of the adenovirus E1 B 175R protein. Gene 1993;124:173-81. [DOI: 10.1016/0378-1119(93)90391-f] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
5 Matsuzaki Y, Edagawa M, Shimizu T, Hara M, Tomita M, Ayabe T, Onitsuka T. Intrapleural hyperthermic perfusion with chemotherapy increases apoptosis in malignant pleuritis. Ann Thorac Surg 2004;78:1769-72. [PMID: 15511471 DOI: 10.1016/j.athoracsur.2004.05.025] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
6 Wang S, Tang S, Chen X, Li X, Jiang S, Li HP, Jia PH, Song MJ, Di P, Li W. Pulchinenoside B4 exerts the protective effects against cisplatin-induced nephrotoxicity through NF-κB and MAPK mediated apoptosis signaling pathways in mice. Chem Biol Interact 2020;331:109233. [PMID: 32991863 DOI: 10.1016/j.cbi.2020.109233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Duan L, Aoyagi M, Tamaki M, Nakagawa K, Nagashima G, Nagasaka Y, Ohno K, Yamamoto K, Hirakawa K. Sensitization of human malignant glioma cell lines to tumor necrosis factor-induced apoptosis by cisplatin. J Neurooncol 2001;52:23-36. [PMID: 11451200 DOI: 10.1023/a:1010685110862] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
8 Marcu LG. Improving therapeutic ratio in head and neck cancer with adjuvant and cisplatin-based treatments. Biomed Res Int 2013;2013:817279. [PMID: 24455727 DOI: 10.1155/2013/817279] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
9 Manguinhas R, Fernandes AS, Costa JG, Saraiva N, Camões SP, Gil N, Rosell R, Castro M, Miranda JP, Oliveira NG. Impact of the APE1 Redox Function Inhibitor E3330 in Non-small Cell Lung Cancer Cells Exposed to Cisplatin: Increased Cytotoxicity and Impairment of Cell Migration and Invasion. Antioxidants (Basel) 2020;9:E550. [PMID: 32599967 DOI: 10.3390/antiox9060550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Gibb RK, Taylor DD, Wan T, O'Connor DM, Doering DL, Gerçel-Taylor C. Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines. Gynecol Oncol 1997;65:13-22. [PMID: 9103385 DOI: 10.1006/gyno.1997.4637] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ng NS, Wu MJ, Myers SJ, Aldrich-wright JR. The in vitro renal cell toxicity of some unconventional anticancer phenanthroline-based platinum(II) complexes. Journal of Inorganic Biochemistry 2018;179:97-106. [DOI: 10.1016/j.jinorgbio.2017.11.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
12 Ghoshal A, Goswami U, Sahoo AK, Chattopadhyay A, Ghosh SS. Targeting Wnt Canonical Signaling by Recombinant sFRP1 Bound Luminescent Au-Nanocluster Embedded Nanoparticles in Cancer Theranostics. ACS Biomater Sci Eng 2015;1:1256-66. [DOI: 10.1021/acsbiomaterials.5b00305] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
13 Krajčí D, Mareš V, Lisá V, Španová A, Vorlíček J. Ultrastructure of nuclei of cisplatin-treated C6 glioma cells undergoing apoptosis. European Journal of Cell Biology 2000;79:365-76. [DOI: 10.1078/s0171-9335(04)70041-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
14 Otto AM, Paddenberg R, Schubert S, Mannherz HG. Cell-cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin. J Cancer Res Clin Oncol 1996;122:603-12. [PMID: 8879258 DOI: 10.1007/BF01221192] [Cited by in Crossref: 45] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
15 Kartalou M, Essigmann JM. Mechanisms of resistance to cisplatin. Mutat Res 2001;478:23-43. [PMID: 11406167 DOI: 10.1016/s0027-5107(01)00141-5] [Cited by in Crossref: 577] [Cited by in F6Publishing: 210] [Article Influence: 28.9] [Reference Citation Analysis]
16 Iwadate Y, Fujimoto S, Sueyoshi K, Namba H, Tagawa M, Yamaura A. Prediction of Drug Cytotoxicity in 9L Rat Brain Tumor by Using Flow Cytometry with a Deoxyribonucleic Acid-binding Dye. Neurosurgery 1997;40:782-8. [DOI: 10.1097/00006123-199704000-00025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
17 Yin D, Kondo S, Barnett GH, Morimura T, Takeuchi J. Tumor Necrosis Factor-?? Induces p53-dependent Apoptosis in Rat Glioma Cells: . Neurosurgery 1995;37:758???763. [DOI: 10.1097/00006123-199510000-00021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
18 Pauwels O, Kiss R. Monitoring of chemotherapy-induced morphonuclear modifications by means of digital cell-image analysis. J Cancer Res Clin Oncol 1993;119:533-40. [DOI: 10.1007/bf01686463] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Marcu L, Bezak E, Olver I, Doorn TV. Tumour resistance to cisplatin: a modelling approach. Phys Med Biol 2005;50:93-102. [DOI: 10.1088/0031-9155/50/1/008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
20 Servidei T, Ferlini C, Riccardi A, Meco D, Scambia G, Segni G, Manzotti C, Riccardi R. The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatin. European Journal of Cancer 2001;37:930-8. [DOI: 10.1016/s0959-8049(01)00061-2] [Cited by in Crossref: 66] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
21 David Jarvis W, Povirk LF, Turner AJ, Traylor RS, Gewirtz DA, Pettit GR, Grant S. Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[β-d-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells. Biochemical Pharmacology 1994;47:839-52. [DOI: 10.1016/0006-2952(94)90484-7] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 2.4] [Reference Citation Analysis]
22 Schoch S, Gajewski S, Rothfuß J, Hartwig A, Köberle B. Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics. Int J Mol Sci 2020;21:E6928. [PMID: 32967255 DOI: 10.3390/ijms21186928] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
23 Jayachandran G, Ueda K, Wang B, Roth JA, Ji L. NPRL2 sensitizes human non-small cell lung cancer (NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway. PLoS One 2010;5:e11994. [PMID: 20700484 DOI: 10.1371/journal.pone.0011994] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
24 Azuma A, Huang P, Matsuda A, Plunkett W. 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrest. Mol Pharmacol 2001;59:725-31. [PMID: 11259616 DOI: 10.1124/mol.59.4.725] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 2.7] [Reference Citation Analysis]
25 Grossmann KF, Brown JC, Moses RE. Cisplatin DNA cross-links do not inhibit S-phase and cause only a G2/M arrest in Saccharomyces cerevisiae. Mutation Research/DNA Repair 1999;434:29-39. [DOI: 10.1016/s0921-8777(99)00011-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
26 Gibalová L, Sereš M, Rusnák A, Ditte P, Labudová M, Uhrík B, Pastorek J, Sedlák J, Breier A, Sulová Z. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation. Toxicol In Vitro 2012;26:435-44. [PMID: 22269388 DOI: 10.1016/j.tiv.2012.01.014] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
27 Brada S, van de Loosdrecht A, Koudstaal J, de Wolf J, Vellenga E. Limited numbers of apoptotic cells in fresh paraffin embedded bone marrow samples of patients with myelodysplastic syndrome. Leukemia Research 2004;28:921-5. [DOI: 10.1016/j.leukres.2004.01.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
28 Yeung T, Fung O, Bashkurov M, Khandani A, Subedar O, Wudwud A, Shaw P, Clarke B, Bartlett J, Rottapel R, Kapus A. Avoidance of apoptotic death via a hyperploid salvage survival pathway after platinum treatment in high grade serous carcinoma cell line models. Oncotarget 2019;10:6691-712. [PMID: 31803363 DOI: 10.18632/oncotarget.27330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Zhivotosky B, Orrenius S. Assessment of apoptosis and necrosis by DNA fragmentation and morphological criteria. Curr Protoc Cell Biol. 2001;Chapter 18:Unit 18.3. [PMID: 18228342 DOI: 10.1002/0471143030.cb1803s12] [Cited by in Crossref: 41] [Cited by in F6Publishing: 49] [Article Influence: 3.2] [Reference Citation Analysis]
30 Chen W, Huang S, Cooper NR. Levels of p53 in Epstein–Barr Virus-Infected Cells Determine Cell Fate: Apoptosis, Cell Cycle Arrest at the G1/S Boundary without Apoptosis, Cell Cycle Arrest at the G2/M Boundary without Apoptosis, or Unrestricted Proliferation. Virology 1998;251:217-26. [DOI: 10.1006/viro.1998.9431] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
31 Ubol S, Tucker PC, Griffin DE, Hardwick JM. Neurovirulent strains of Alphavirus induce apoptosis in bcl-2-expressing cells: role of a single amino acid change in the E2 glycoprotein. Proc Natl Acad Sci U S A 1994;91:5202-6. [PMID: 8197207 DOI: 10.1073/pnas.91.11.5202] [Cited by in Crossref: 110] [Cited by in F6Publishing: 100] [Article Influence: 4.1] [Reference Citation Analysis]
32 Wang Z, Butner JD, Cristini V, Deisboeck TS. Integrated PK-PD and agent-based modeling in oncology. J Pharmacokinet Pharmacodyn 2015;42:179-89. [PMID: 25588379 DOI: 10.1007/s10928-015-9403-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 6.5] [Reference Citation Analysis]
33 Hoh DJ, Liu CY, Chen JC, Pagnini PG, Yu C, Wang MY, Apuzzo ML. CHAINED LIGHTNING. Neurosurgery 2007;61:1111-30. [DOI: 10.1227/01.neu.0000306089.22894.4e] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
34 Vesela E, Chroma K, Turi Z, Mistrik M. Common Chemical Inductors of Replication Stress:  Focus on Cell-Based Studies. Biomolecules 2017;7:E19. [PMID: 28230817 DOI: 10.3390/biom7010019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 8] [Article Influence: 10.3] [Reference Citation Analysis]
35 Binder C, Hiddemann W. Programmed cell death — many questions still to be answered. Ann Hematol 1994;69:45-55. [DOI: 10.1007/bf01698481] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
36 Pappa A, Chen C, Koutalos Y, Townsend AJ, Vasiliou V. Aldh3a1 protects human corneal epithelial cells from ultraviolet- and 4-hydroxy-2-nonenal-induced oxidative damage. Free Radic Biol Med 2003;34:1178-89. [PMID: 12706498 DOI: 10.1016/s0891-5849(03)00070-4] [Cited by in Crossref: 83] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
37 Bicknell G, Snowden R, Cohen G. Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukaemic cell line, U937. Journal of Cell Science 1994;107:2483-9. [DOI: 10.1242/jcs.107.9.2483] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
38 Joe AK, Ferrari G, Jiang HH, Liang XH, Levine B. Dominant inhibitory Ras delays Sindbis virus-induced apoptosis in neuronal cells. J Virol 1996;70:7744-51. [PMID: 8892895 DOI: 10.1128/JVI.70.11.7744-7751.1996] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
39 Chu G. Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. Journal of Biological Chemistry 1994;269:787-90. [DOI: 10.1016/s0021-9258(17)42175-2] [Cited by in Crossref: 286] [Article Influence: 10.6] [Reference Citation Analysis]
40 Zhang X, Giangreco L, Broome HE, Dargan CM, Swain SL. Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J Exp Med 1995;182:699-709. [PMID: 7650478 DOI: 10.1084/jem.182.3.699] [Cited by in Crossref: 115] [Cited by in F6Publishing: 111] [Article Influence: 4.4] [Reference Citation Analysis]
41 Fadeel B, Åhlin A, Henter J, Orrenius S, Hampton MB. Involvement of Caspases in Neutrophil Apoptosis: Regulation by Reactive Oxygen Species. Blood 1998;92:4808-18. [DOI: 10.1182/blood.v92.12.4808.424k01_4808_4818] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
42 Siemer S, Ørnskov D, Guerra B, Boldyreff B, Issinger O. Determination of mRNA, and protein levels of p53, MDM2 and protein kinase CK2 subunits in F9 cells after treatment with the apoptosis-inducing drugs cisplatin and carboplatin. The International Journal of Biochemistry & Cell Biology 1999;31:661-70. [DOI: 10.1016/s1357-2725(99)00020-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
43 Wenande E, Tam J, Bhayana B, Schlosser SK, Ishak E, Farinelli WA, Chlopik A, Hoang MP, Pinkhasov OR, Caravan P, Rox Anderson R, Haedersdal M. Laser-assisted delivery of synergistic combination chemotherapy in in vivo skin. Journal of Controlled Release 2018;275:242-53. [DOI: 10.1016/j.jconrel.2018.02.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
44 Micheau O, Solary E, Hammann A, Martin F, Dimanche-Boitrel MT. Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity. J Natl Cancer Inst. 1997;89:783-789. [PMID: 9182976 DOI: 10.1093/jnci/89.11.783] [Cited by in Crossref: 201] [Cited by in F6Publishing: 187] [Article Influence: 8.4] [Reference Citation Analysis]
45 Matsumoto Y, Hayakawa A, Tamada Y, Mori H, Ohashi M. Upregulated expression of Fas antigen on cultured human keratinocytes with induction of apoptosis by cisplatin. Arch Dermatol Res 1996;288:267-9. [DOI: 10.1007/bf02530099] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
46 Gamarra-Luques CD, Goyeneche AA, Hapon MB, Telleria CM. Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy. BMC Cancer 2012;12:200. [PMID: 22642877 DOI: 10.1186/1471-2407-12-200] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
47 Li S, Peng F, Ning Y, Jiang P, Peng J, Ding X, Zhang J, Jiang T, Xiang S. SNHG16 as the miRNA let-7b-5p sponge facilitates the G2/M and epithelial-mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma. J Cell Biochem. 2020;121:2543-2558. [PMID: 31696971 DOI: 10.1002/jcb.29477] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
48 Schlegel J, Peters I, Orrenius S. Isolation and partial characterization of a protease involved in Fas-induced apoptosis. FEBS Lett 1995;364:139-42. [PMID: 7538470 DOI: 10.1016/0014-5793(95)00374-i] [Cited by in Crossref: 30] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
49 Pastrone I, Viale M, Cafaggi S, Mariggiò MA, Parodi A, Esposito M. Effect of the cisplatin-procaine complex DPR in combination with several anticancer agents on murine P388 leukemic cells in vitro and in vivo. Invest New Drugs 1998-1999;16:297-302. [PMID: 10426661 DOI: 10.1023/a:1006228027066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
50 Arifin MT, Hama S, Kajiwara Y, Sugiyama K, Saito T, Matsuura S, Yamasaki F, Arita K, Kurisu K. Cytoplasmic, but not nuclear, p16 expression may signal poor prognosis in high-grade astrocytomas. J Neurooncol 2006;77:273-7. [PMID: 16614947 DOI: 10.1007/s11060-005-9037-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
51 Kawasaki M, Nakanishi Y, Kuwano K, Takayama K, Kiyohara C, Hara N. Immunohistochemically detected p53 and P-glycoprotein predict the response to chemotherapy in lung cancer. European Journal of Cancer 1998;34:1352-7. [DOI: 10.1016/s0959-8049(98)00067-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
52 Pasternak MM, Strohm EM, Berndl ES, Kolios MC. Properties of cells through life and death - an acoustic microscopy investigation. Cell Cycle 2015;14:2891-8. [PMID: 26178635 DOI: 10.1080/15384101.2015.1069925] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
53 Fabiani R, De Bartolomeo A, Rosignoli P, Servili M, Montedoro GF, Morozzi G. Cancer chemoprevention by hydroxytyrosol isolated from virgin olive oil through G1 cell cycle arrest and apoptosis: . European Journal of Cancer Prevention 2002;11:351-8. [DOI: 10.1097/00008469-200208000-00006] [Cited by in Crossref: 143] [Cited by in F6Publishing: 125] [Article Influence: 7.5] [Reference Citation Analysis]
54 Gasperin P, Gozy M, Pauwels O, Frohling J, Van Houtte P, Pasteels J, Kiss R. Monitoring of radiotherapy-induced morphonuclear modifications in the mxt mouse mammary carcinoma by means of digital cell image analysis. International Journal of Radiation Oncology*Biology*Physics 1992;22:979-87. [DOI: 10.1016/0360-3016(92)90797-l] [Cited by in Crossref: 13] [Article Influence: 0.4] [Reference Citation Analysis]
55 Yang X, Cheng L, Li M, Shi H, Ren H, Ding Z, Liu F, Wang Y, Cheng C. High expression of SGTA in esophageal squamous cell carcinoma correlates with proliferation and poor prognosis. J Cell Biochem 2014;115:141-50. [PMID: 23939810 DOI: 10.1002/jcb.24641] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
56 Vermes I, Haanen C. Apoptosis and Programmed Cell Death in Health and Disease. Elsevier; 1994. pp. 177-246. [DOI: 10.1016/s0065-2423(08)60336-4] [Cited by in Crossref: 82] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
57 Yoon HS, Moon SC, Kim ND, Park BS, Jeong MH, Yoo YH. Genistein Induces Apoptosis of RPE-J Cells by Opening Mitochondrial PTP. Biochemical and Biophysical Research Communications 2000;276:151-6. [DOI: 10.1006/bbrc.2000.3445] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 3.5] [Reference Citation Analysis]
58 Spinozzi F, Pagliacci MC, Migliorati G, Moraca R, Grignani F, Riccardi C, Nicoletti I. The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. Leuk Res. 1994;18:431-439. [PMID: 8207961 DOI: 10.1016/0145-2126(94)90079-5] [Cited by in Crossref: 147] [Cited by in F6Publishing: 135] [Article Influence: 5.4] [Reference Citation Analysis]
59 Kass GE, Eriksson JE, Weis M, Orrenius S, Chow SC. Chromatin condensation during apoptosis requires ATP. Biochem J 1996;318 ( Pt 3):749-52. [PMID: 8836114 DOI: 10.1042/bj3180749] [Cited by in Crossref: 110] [Cited by in F6Publishing: 109] [Article Influence: 4.4] [Reference Citation Analysis]
60 Bhuyan BK, Smith KS, Adams EG, Wallace TL, Von Hoff DD, Li LH. Adozelesin, a potent new alkylating agent: cell-killing kinetics and cell-cycle effects. Cancer Chemother Pharmacol 1992;30:348-54. [DOI: 10.1007/bf00689961] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
61 Ng CE, Mcgovern KA, Wehrle JP, Glickson JD. 31p nme spectroscopic study of the effects of γ-irradiation on rif-1 tumor cells perfusedin vitro. Magn Reson Med 1992;27:296-309. [DOI: 10.1002/mrm.1910270209] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
62 Iyengar M, O'Hayer P, Cole A, Sebastian T, Yang K, Coffman L, Buckanovich RJ. CDK4/6 inhibition as maintenance and combination therapy for high grade serous ovarian cancer. Oncotarget 2018;9:15658-72. [PMID: 29644000 DOI: 10.18632/oncotarget.24585] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
63 Fry DW. Biochemical pharmacology of anthracenediones and anthrapyrazoles. Pharmacology & Therapeutics 1991;52:109-25. [DOI: 10.1016/0163-7258(91)90089-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
64 Zwang TJ, Singh K, Johal MS, Selassie CR. Elucidation of the Molecular Interaction between Cisplatin and Flavonol(s) and their Effect on DNA Binding. J Med Chem 2013;56:1491-8. [DOI: 10.1021/jm3016798] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
65 Weinrib L, Li J, Donovan J, Huang D, Liu F. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma. Cancer Gene Ther 2001;8:352-60. [DOI: 10.1038/sj.cgt.7700319] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
66 Nematbakhsh M, Pezeshki Z, Eshraghi Jazi F, Mazaheri B, Moeini M, Safari T, Azarkish F, Moslemi F, Maleki M, Rezaei A, Saberi Sh, Dehghani A, Malek M, Mansouri A, Ghasemi M, Zeinali F, Zamani Z, Navidi M, Jilanchi S, Shirdavani S, Ashrafi F. Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender Differences. Asian Pac J Cancer Prev 2017;18:295-314. [PMID: 28345324 DOI: 10.22034/APJCP.2017.18.2.295] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
67 Krarup-Hansen A, Rietz B, Krarup C, Heydorn K, Rørth M, Schmalbruch H. Histology and platinum content of sensory ganglia and sural nerves in patients treated with cisplatin and carboplatin: an autopsy study. Neuropathol Appl Neurobiol 1999;25:29-40. [PMID: 10194773 DOI: 10.1046/j.1365-2990.1999.00160.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 2.2] [Reference Citation Analysis]
68 Bär SI, Gold M, Schleser SW, Rehm T, Bär A, Köhler L, Carnell LR, Biersack B, Schobert R. Guided Antitumoural Drugs: (Imidazol-2-ylidene)(L)gold(I) Complexes Seeking Cellular Targets Controlled by the Nature of Ligand L. Chemistry 2021;27:5003-10. [PMID: 33369765 DOI: 10.1002/chem.202005451] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Reddy KB. Epidermal growth factor induced apoptosis. Apoptosis 1996;1:33-9. [DOI: 10.1007/bf00142076] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
70 Eastman A, Barry MA. The Origins of DNA Breaks: A Consequence of DNA Damage, DNA Repair, or Apoptosis?: New Drugs. Cancer Investigation 2009;10:229-40. [DOI: 10.3109/07357909209032765] [Cited by in Crossref: 186] [Cited by in F6Publishing: 165] [Article Influence: 15.5] [Reference Citation Analysis]
71 Higdon RE, Marchetti F, Mailhes JB, Phillips GL. The effects of cisplatin on murine metaphase II oocytes. Gynecol Oncol 1992;47:348-52. [PMID: 1473748 DOI: 10.1016/0090-8258(92)90138-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
72 Ceruti S, Franceschi C, Barbieri D, Malorni W, Camurri A, Giammarioli AM, Ambrosini A, Racagni G, Cattabeni F, Abbracchio MP. Apoptosis induced by 2-chloro-adenosine and 2-chloro-2?-deoxy-adenosine in a human astrocytoma cell line: Differential mechanisms and possible clinical relevance. J Neurosci Res 2000;60:388-400. [DOI: 10.1002/(sici)1097-4547(20000501)60:3<388::aid-jnr14>3.0.co;2-v] [Cited by in Crossref: 33] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
73 Sun X, Snowden RT, Skilleter DN, Dinsdale D, Ormerod MG, Cohen GM. A flow-cytometric method for the separation and quantitation of normal and apoptotic thymocytes. Analytical Biochemistry 1992;204:351-6. [DOI: 10.1016/0003-2697(92)90251-2] [Cited by in Crossref: 92] [Cited by in F6Publishing: 91] [Article Influence: 3.2] [Reference Citation Analysis]
74 Vock E, Lutz W, Ilinskaya O, Vamvakas S. Discrimination between genotoxicity and cytotoxicity for the induction of DNA double-strand breaks in cells treated with aldehydes and diepoxides. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 1999;441:85-93. [DOI: 10.1016/s1383-5718(99)00038-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
75 Sun X, Cohen G. Mg(2+)-dependent cleavage of DNA into kilobase pair fragments is responsible for the initial degradation of DNA in apoptosis. Journal of Biological Chemistry 1994;269:14857-60. [DOI: 10.1016/s0021-9258(17)36542-0] [Cited by in Crossref: 54] [Article Influence: 2.0] [Reference Citation Analysis]
76 Kondo S, Yin D, Takeuchi J, Morimura T, Oda Y, Kikuchi H. bcl-2 gene enables rescue from in vitro myelosuppression (bone marrow cell death) induced by chemotherapy. Br J Cancer 1994;70:421-6. [PMID: 8080725 DOI: 10.1038/bjc.1994.321] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
77 Kawaguchi J, Adachi S, Yasuda I, Yamauchi T, Nakashima M, Ohno T, Shimizu M, Yoshioka T, Itani M, Kozawa O, Moriwaki H. Cisplatin and ultra-violet-C synergistically down-regulate receptor tyrosine kinases in human colorectal cancer cells. Mol Cancer 2012;11:45. [PMID: 22788833 DOI: 10.1186/1476-4598-11-45] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
78 Sleiman RJ, Catchpoole DR, Stewart BW. Drug-induced death of leukaemic cells after G2/M arrest: higher order DNA fragmentation as an indicator of mechanism. Br J Cancer 1998;77:40-50. [PMID: 9459144 DOI: 10.1038/bjc.1998.7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
79 Levine B, Huang Q, Isaacs JT, Reed JC, Griffin DE, Hardwick JM. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 1993;361:739-42. [DOI: 10.1038/361739a0] [Cited by in Crossref: 386] [Cited by in F6Publishing: 369] [Article Influence: 13.8] [Reference Citation Analysis]
80 Sen S, D'Incalci M. Apoptosis. Biochemical events and relevance to cancer chemotherapy. FEBS Lett 1992;307:122-7. [PMID: 1639187 DOI: 10.1016/0014-5793(92)80914-3] [Cited by in Crossref: 169] [Cited by in F6Publishing: 176] [Article Influence: 5.8] [Reference Citation Analysis]
81 Macciò A, Madeddu C. Cisplatin : an old drug with a newfound efficacy -- from mechanisms of action to cytotoxicity. Expert Opin Pharmacother 2013;14:1839-57. [PMID: 23876094 DOI: 10.1517/14656566.2013.813934] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 6.8] [Reference Citation Analysis]
82 Marcu L, Bezak E. Modelling of tumour repopulation after chemotherapy. Australas Phys Eng Sci Med 2010;33:265-70. [PMID: 20652783 DOI: 10.1007/s13246-010-0026-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
83 Ormerod MG, Orr RM, O'Neill CF, Chwalinski T, Titley JC, Kelland LR, Harrap KR. The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric study. Br J Cancer 1996;74:1935-43. [PMID: 8980393 DOI: 10.1038/bjc.1996.656] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
84 Payne CM, Bernstein H, Bernstein C, Garewal H. Role of Apoptosis in Biology and Pathology: Resistance to Apoptosis in Colon Carcinogenesis. Ultrastructural Pathology 2009;19:221-48. [DOI: 10.3109/01913129509064227] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
85 Rossini E, Bosatta V, Abate A, Fragni M, Salvi V, Basnet RM, Zizioli D, Bosisio D, Piovani G, Valcamonico F, Mirabella G, Berruti A, Memo M, Sigala S. Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib. Clin Genitourin Cancer 2021;19:316-24. [PMID: 33676835 DOI: 10.1016/j.clgc.2021.01.006] [Reference Citation Analysis]
86 Büning H, Altman J, Beck W, Zorbas H. Molecular Interaction of DNA with Bisplatinum(II) Complexes Having Bis(Vicinal 1,2-Diamines) as Ligand. Biochemistry 1997;36:11408-18. [DOI: 10.1021/bi970741l] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
87 Xiao H, Qi R, Li T, Awuah SG, Zheng Y, Wei W, Kang X, Song H, Wang Y, Yu Y, Bird MA, Jing X, Yaffe MB, Birrer MJ, Ghoroghchian PP. Maximizing Synergistic Activity When Combining RNAi and Platinum-Based Anticancer Agents. J Am Chem Soc 2017;139:3033-44. [PMID: 28166401 DOI: 10.1021/jacs.6b12108] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 11.5] [Reference Citation Analysis]
88 Billecke C, Finniss S, Tahash L, Miller C, Mikkelsen T, Farrell NP, Bögler O. Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma. Neuro Oncol 2006;8:215-26. [PMID: 16723633 DOI: 10.1215/15228517-2006-004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 4.5] [Reference Citation Analysis]
89 Duman RK, Heath RT, Bose RN. Inhibition of Escherichia coli DNA polymerase-I by the anti-cancer drug cis -diaminedichloroplatinum(II): what roles do polymerases play in cis -platin-induced cytotoxicity? FEBS Letters 1999;455:49-54. [DOI: 10.1016/s0014-5793(99)00800-5] [Cited by in Crossref: 8] [Article Influence: 0.4] [Reference Citation Analysis]
90 Olie RA, Boersma AW, Dekker MC, Nooter K, Looijenga LH, Oosterhuis JW. Apoptosis of human seminoma cells upon disruption of their microenvironment. Br J Cancer 1996;73:1031-6. [PMID: 8624259 DOI: 10.1038/bjc.1996.200] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
91 Johnson CS. Interleukin-1: therapeutic potential for solid tumors. Cancer Invest 1993;11:600-8. [PMID: 8402228 DOI: 10.3109/07357909309011679] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
92 Chipchase MD, O'neill M, Melton DW. Characterization of premature liver polyploidy in DNA repair (Ercc1)-deficient mice. Hepatology 2003;38:958-66. [DOI: 10.1002/hep.1840380422] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
93 Schloffer D, Horky M, Kotala V, Wȩsierska-ga̧dek J. Induction of cell cycle arrest and apoptosis in human cervix carcinoma cells during therapy by cisplatin. Cancer Detection and Prevention 2003;27:481-93. [DOI: 10.1016/j.cdp.2003.07.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
94 Ohtsubo T, Igawa H, Saito T, Matsumoto H, Park HJ, Song CW, Kano E, Saito H. Acidic environment modifies heat- or radiation-induced apoptosis in human maxillary cancer cells. International Journal of Radiation Oncology*Biology*Physics 2001;49:1391-8. [DOI: 10.1016/s0360-3016(00)01590-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
95 Evans MD, Wolfe JT, Perrett D, Lunec J, Herbert KE. Analysis of internucleosomal DNA fragmentation in apoptotic thymocytes by dynamic sieving capillary electrophoresis. Journal of Chromatography A 1995;700:151-62. [DOI: 10.1016/0021-9673(94)01263-e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Bassett S, Urrabaz R, Sun D. Cellular response and molecular mechanism of antitumor activity by leinamycin in MiaPaCa human pancreatic cancer cells. Anti-Cancer Drugs 2004;15:689-96. [DOI: 10.1097/01.cad.0000136886.72917.6f] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
97 Thakor FK, Wan KW, Welsby PJ, Welsby G. Pharmacological effects of asiatic acid in glioblastoma cells under hypoxia. Mol Cell Biochem 2017;430:179-90. [PMID: 28205096 DOI: 10.1007/s11010-017-2965-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
98 Yin A, Jiang Y, Zhang X, Zhao J, Luo H. Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo. European Journal of Pharmacology 2010;649:120-6. [DOI: 10.1016/j.ejphar.2010.09.040] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
99 Donaldson KL, Goolsby GL, Wahl AF. Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int J Cancer 1994;57:847-55. [DOI: 10.1002/ijc.2910570614] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 4.3] [Reference Citation Analysis]
100 Kong L, Liu B, Zhang C, Wang B, Wang H, Song X, Yang Y, Ren X, Yin L, Kong H, Ma H. The therapeutic potential of sulforaphane on light-induced photoreceptor degeneration through antiapoptosis and antioxidant protection. Neurochem Int 2016;100:52-61. [PMID: 27567738 DOI: 10.1016/j.neuint.2016.08.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
101 Minnema D. Neurotoxic Metals and Neuronal Signalling Processes. In: Isaacson RL, Jensen KF, editors. The Vulnerable Brain and Environmental Risks. Boston: Springer US; 1992. pp. 83-109. [DOI: 10.1007/978-1-4615-3330-6_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
102 Yang X, Xiong H, Guan ZZ, Okai I, Ye D, Song Y, Li X, Wang L, Liu L, Du S, Lin D, Shao S. Higher expression of Caveolin-1 inhibits human small cell lung cancer (SCLC) apoptosis in vitro. Cancer Invest 2012;30:453-62. [PMID: 22545709 DOI: 10.3109/07357907.2012.675384] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
103 Pagliacci MC, Smacchia M, Migliorati G, Grignani F, Riccardi C, Nicoletti I. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur J Cancer. 1994;30A:1675-1682. [PMID: 7833143 DOI: 10.1016/0959-8049(94)00262-4] [Cited by in Crossref: 125] [Cited by in F6Publishing: 112] [Article Influence: 4.8] [Reference Citation Analysis]
104 Pizarro A, Barry N, Sadler P. Metal–DNA Coordination Complexes. Comprehensive Inorganic Chemistry II. Elsevier; 2013. pp. 751-84. [DOI: 10.1016/b978-0-08-097774-4.00330-2] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
105 Nabeya Y, Loganzo F, Maslak P, Lai L, de Oliveira AR, Schwartz GK, Blundell ML, Altorki NK, Kelsen DP, Albino AP. The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents. Int J Cancer. 1995;64:37-46. [PMID: 7665247 DOI: 10.1002/ijc.2910640109] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 2.4] [Reference Citation Analysis]
106 Kim I, Lee J, Sohn H, Kim H, Kim S. Prostaglandin A 2 and Δ 12 -prostaglandin J 2 induce apoptosis in L1210 cells. FEBS Letters 1993;321:209-14. [DOI: 10.1016/0014-5793(93)80110-g] [Cited by in Crossref: 76] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
107 Wrighton KH, Prêle CM, Sunters A, Yeudall WA. Aberrant p53 alters DNA damage checkpoints in response to cisplatin: Downregulation of CDK expression and activity: Checkpoint Alteration by Aberrant p53. Int J Cancer 2004;112:760-70. [DOI: 10.1002/ijc.20446] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
108 Screnci D, Er HM, Hambley TW, Galettis P, Brouwer W, McKeage MJ. Stereoselective peripheral sensory neurotoxicity of diaminocyclohexane platinum enantiomers related to ormaplatin and oxaliplatin. Br J Cancer 1997;76:502-10. [PMID: 9275028 DOI: 10.1038/bjc.1997.416] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis]
109 Maldonado V, Meléndez-Zajgla J, Ortega A. Modulation of NF-kappa B, and Bcl-2 in apoptosis induced by cisplatin in HeLa cells. Mutat Res 1997;381:67-75. [PMID: 9403032 DOI: 10.1016/s0027-5107(97)00150-4] [Cited by in Crossref: 48] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
110 Härmälä-braskén A, Mikhailov A, Söderström TS, Meinander A, Holmström TH, Damuni Z, Eriksson JE. Type-2A protein phosphatase activity is required to maintain death receptor responsiveness. Oncogene 2003;22:7677-86. [DOI: 10.1038/sj.onc.1207077] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
111 Fallahi H, Godini R. System-level responses to cisplatin in pro-apoptotic stages of breast cancer MCF-7 cell line. Comput Biol Chem 2019;83:107155. [PMID: 31706153 DOI: 10.1016/j.compbiolchem.2019.107155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Ronai Z, Tillotson JK, Traganos F, Darzynkiewicz Z, Conaway CC, Upadhyaya P, El-bayoumy K. Effects of organic and inorganic selenium compounds on rat mammary tumor cells. Int J Cancer 1995;63:428-34. [DOI: 10.1002/ijc.2910630322] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 1.7] [Reference Citation Analysis]
113 Yu L, Orlandi L, Wang P, Orr MS, Senderowicz AM, Sausville EA, Silvestrini R, Watanabe N, Piwnica-worms H, O'connor PM. UCN-01 Abrogates G2 Arrest through a Cdc2-dependent Pathway That Is Associated with Inactivation of the Wee1Hu Kinase and Activation of the Cdc25C Phosphatase. Journal of Biological Chemistry 1998;273:33455-64. [DOI: 10.1074/jbc.273.50.33455] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 2.4] [Reference Citation Analysis]
114 Yoon YS, Kim JW, Kang KW, Kim YS, Choi KH, Joe CO. Poly(ADP-ribosyl)ation of Histone H1 Correlates with Internucleosomal DNA Fragmentation during Apoptosis. Journal of Biological Chemistry 1996;271:9129-34. [DOI: 10.1074/jbc.271.15.9129] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 2.2] [Reference Citation Analysis]
115 Roman S, Petrusca D, Moldovan I, Paraoan M, Petrescu A, Damian D, Noica N, Sulica A. Evaluation of apoptosis of tumor and of apparently normal cells in human renal carcinoma. Immunology Letters 1999;67:15-22. [DOI: 10.1016/s0165-2478(98)00110-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
116 Dronkert ML, Kanaar R. Repair of DNA interstrand cross-links. Mutation Research/DNA Repair 2001;486:217-47. [DOI: 10.1016/s0921-8777(01)00092-1] [Cited by in Crossref: 393] [Cited by in F6Publishing: 190] [Article Influence: 19.7] [Reference Citation Analysis]
117 Hsieh CH, Hou ML, Chiang MH, Tai HC, Tien HJ, Wang LY, Tsai TH, Chen YJ. Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin. J Transl Med 2013;11:231. [PMID: 24066670 DOI: 10.1186/1479-5876-11-231] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
118 Zustiak SP. The role of matrix compliance on cell responses to drugs and toxins: towards predictive drug screening platforms. Macromol Biosci 2015;15:589-99. [PMID: 25654999 DOI: 10.1002/mabi.201400507] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
119 Davidoff AN, Mendelow BV. Unexpected cytokinetic effects induced by puromycin include a G2-arrest, a metaphase-mitoticarrest, and apoptosis. Leukemia Research 1992;16:1077-85. [DOI: 10.1016/0145-2126(92)90046-a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
120 O'Neill CF, Ormerod MG, Robertson D, Titley JC, Cumber-Walsweer Y, Kelland LR. Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex. Br J Cancer 1996;74:1037-45. [PMID: 8855971 DOI: 10.1038/bjc.1996.486] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
121 Wolfe JT, Ross D, Cohen GM. A role for metals and free radicals in the induction of apoptosis in thymocytes. FEBS Letters 1994;352:58-62. [DOI: 10.1016/0014-5793(94)00920-1] [Cited by in Crossref: 118] [Cited by in F6Publishing: 118] [Article Influence: 5.9] [Reference Citation Analysis]
122 Fadeel B, Åhlin A, Henter J, Orrenius S, Hampton MB. Involvement of Caspases in Neutrophil Apoptosis: Regulation by Reactive Oxygen Species. Blood 1998;92:4808-18. [DOI: 10.1182/blood.v92.12.4808] [Cited by in Crossref: 244] [Article Influence: 10.6] [Reference Citation Analysis]
123 Sen S. Programmed cell death: concept, mechanism and control. Biol Rev Camb Philos Soc 1992;67:287-319. [PMID: 1420728 DOI: 10.1111/j.1469-185x.1992.tb00727.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
124 Lin HL, Parsels LA, Maybaum J, Hollenberg PF. N-Nitrosodimethylamine-mediated cytotoxicity in a cell line expressing P450 2E1: evidence for apoptotic cell death. Toxicol Appl Pharmacol 1999;157:117-24. [PMID: 10366544 DOI: 10.1006/taap.1999.8651] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 1.7] [Reference Citation Analysis]
125 Cocetta V, Ragazzi E, Montopoli M. Links between cancer metabolism and cisplatin resistance. Int Rev Cell Mol Biol 2020;354:107-64. [PMID: 32475471 DOI: 10.1016/bs.ircmb.2020.01.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
126 Fan J, Banerjee D, Stambrook PJ, Bertino JR. Modulation of cytotoxicity of chemotherapeutic drugs by activated H-γas. Biochemical Pharmacology 1997;53:1203-9. [DOI: 10.1016/s0006-2952(97)00101-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
127 Chow SC, Weis M, Kass GE, Holmström TH, Eriksson JE, Orrenius S. Involvement of multiple proteases during Fas-mediated apoptosis in T lymphocytes. FEBS Lett 1995;364:134-8. [PMID: 7538469 DOI: 10.1016/0014-5793(95)00370-o] [Cited by in Crossref: 90] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
128 Crul M, Schellens JH, Beijnen JH, Maliepaard M. Cisplatin resistance and DNA repair. Cancer Treat Rev. 1997;23:341-366. [PMID: 9465884 DOI: 10.1016/s0305-7372(97)90032-3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
129 Dixit M, Yang J, Poirier MC, Price JO, Andrews PA, Arteaga CL. Abrogation of Cisplatin-Induced Programmed Cell Death in Human Breast Cancer Cells by Epidermal Growth Factor Antisense RNA. JNCI Journal of the National Cancer Institute 1997;89:365-72. [DOI: 10.1093/jnci/89.5.365] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 2.2] [Reference Citation Analysis]
130 Kashanchi F, Melpolder JC, Epstein JS, Sadaie MR. Rapid and sensitive detection of cell-associated HIV-1 in latently infected cell lines and in patient cells using sodium-n-butyrate induction and RT-PCR. J Med Virol 1997;52:179-89. [DOI: 10.1002/(sici)1096-9071(199706)52:2<179::aid-jmv11>3.0.co;2-g] [Cited by in Crossref: 20] [Article Influence: 0.8] [Reference Citation Analysis]
131 Marcu LG, Harriss-Phillips WM. In silico modelling of treatment-induced tumour cell kill: developments and advances. Comput Math Methods Med 2012;2012:960256. [PMID: 22852024 DOI: 10.1155/2012/960256] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
132 Medrano A, Dennis SM, Alvarez-valdés A, Perles J, Mcgregor Mason T, Quiroga AG. Synthesis, cytotoxicity, DNA interaction and cell cycle studies of trans-diiodophosphine Pt( ii ) complexes. Dalton Trans 2015;44:3557-62. [DOI: 10.1039/c4dt02392g] [Cited by in Crossref: 11] [Article Influence: 1.8] [Reference Citation Analysis]
133 Yoo T, Lim K, Sultan MT, Lee JS, Park J, Ju HW, Park C, Jang M. The real-time monitoring of drug reaction in HeLa cancer cell using temperature/impedance integrated biosensors. Sensors and Actuators B: Chemical 2019;291:17-24. [DOI: 10.1016/j.snb.2019.03.145] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
134 Kondo S, Yin D, Morimura T, Kubo H, Nakatsu S, Takeuchi J. Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells. Br J Cancer 1995;71:282-9. [PMID: 7841041 DOI: 10.1038/bjc.1995.57] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 1.0] [Reference Citation Analysis]
135 McAuliffe SM, Morgan SL, Wyant GA, Tran LT, Muto KW, Chen YS, Chin KT, Partridge JC, Poole BB, Cheng KH. Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy. Proc Natl Acad Sci USA. 2012;109:E2939-E2948. [PMID: 23019585 DOI: 10.1073/pnas.1206400109] [Cited by in Crossref: 216] [Cited by in F6Publishing: 206] [Article Influence: 24.0] [Reference Citation Analysis]
136 Harmon BV, Ishii H, Allan DJ. Glutamic acid and tryptophan do not prevent vinblastine-induced apoptosis in a human lymphoma cell line. Cell Prolif 1994;27:455-64. [DOI: 10.1111/j.1365-2184.1994.tb01475.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
137 Cui L, Liang B, Yang Y, Zhu M, Kwong J, Zheng H, Wang CC. Inhibition of coiled coil domain containing protein 69 enhances platinum-induced apoptosis in ovarian cancer cells. Oncotarget 2017;8:101634-48. [PMID: 29254192 DOI: 10.18632/oncotarget.21356] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
138 Eastman A, Barry M. Activation of a Genetic Program for Cell Death. In: Howell SB, editor. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. Boston: Springer US; 1991. pp. 195-202. [DOI: 10.1007/978-1-4899-0738-7_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
139 Perez R. Cellular and molecular determinants of cisplatin resistance. European Journal of Cancer 1998;34:1535-42. [DOI: 10.1016/s0959-8049(98)00227-5] [Cited by in Crossref: 239] [Cited by in F6Publishing: 70] [Article Influence: 10.4] [Reference Citation Analysis]
140 Eastman A, Barry MA, Demarcq C, Li J, Reynolds JE. Endonucleases Associated with Apoptosis. In: Mihich E, Schimke RT, editors. Apoptosis. Boston: Springer US; 1994. pp. 249-64. [DOI: 10.1007/978-1-4757-9217-1_16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
141 Ferreira E, Munyaneza A, Omondi B, Meijboom R, Cronjé MJ. The effect of 1:2 Ag(I) thiocyanate complexes in MCF-7 breast cancer cells. Biometals 2015;28:765-81. [DOI: 10.1007/s10534-015-9865-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
142 Gozy M, Pauwels O, Gasperin P, Pasteels J, Van Houtte P, Kiss R. In vitro characterization of radiotherapy-induced morphonuclear modifications on chemosensitive as opposed to chemoresistant neoplastic cells. International Journal of Radiation Oncology*Biology*Physics 1993;27:83-91. [DOI: 10.1016/0360-3016(93)90424-t] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
143 Cohen GM, Sun XM, Snowden RT, Dinsdale D, Skilleter DN. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J 1992;286 ( Pt 2):331-4. [PMID: 1530564 DOI: 10.1042/bj2860331] [Cited by in Crossref: 450] [Cited by in F6Publishing: 450] [Article Influence: 15.5] [Reference Citation Analysis]
144 Zhivotovsky B, Samali A, Orrenius S. Determination of Apoptosis and Necrosis. Current Protocols in Toxicology 1999;00. [DOI: 10.1002/0471140856.tx0202s00] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
145 Eastman A. The Importance of p53 Signaling in the Response of Cells to Checkpoint Inhibitors. In: Siddik ZH, editor. Checkpoint Controls and Targets in Cancer Therapy. Totowa: Humana Press; 2009. pp. 189-98. [DOI: 10.1007/978-1-60761-178-3_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
146 Brown D, Sun X, Cohen G. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. Journal of Biological Chemistry 1993;268:3037-9. [DOI: 10.1016/s0021-9258(18)53654-1] [Cited by in Crossref: 222] [Article Influence: 7.9] [Reference Citation Analysis]
147 Chang KE, Wei BR, Madigan JP, Hall MD, Simpson RM, Zhuang Z, Gottesman MM. The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicity. Mol Cancer Ther 2015;14:90-100. [PMID: 25376608 DOI: 10.1158/1535-7163.MCT-14-0496] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
148 Piacentini M, Annicchiarico-petruzzelli M, Oliverio S, Piredda L, Biedler JL, Melino G. Phenotype-specific “tissue” transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: Correlation with cell death by apoptosis. Int J Cancer 1992;52:271-8. [DOI: 10.1002/ijc.2910520220] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 2.9] [Reference Citation Analysis]
149 Markovits J, Larsen A, Ségal-bendirdjian E, Fossé P, Saucier J, Gazit A, Levitzki A, Umezawa K, Jacquemin-sablon A. Inhibition of DNA topoisomerases I and II and induction of apoptosis by erbstatin and tyrphostin derivatives. Biochemical Pharmacology 1994;48:549-60. [DOI: 10.1016/0006-2952(94)90285-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
150 Chang Q, Ornatsky OI, Koch CJ, Chaudary N, Marie-egyptienne DT, Hill RP, Tanner SD, Hedley DW. Single-cell measurement of the uptake, intratumoral distribution and cell cycle effects of cisplatin using mass cytometry: Single-cell measurement of cisplatin uptake. Int J Cancer 2015;136:1202-9. [DOI: 10.1002/ijc.29074] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
151 Pörn-ares M, Chow SC, Slotte J, Orrenius S. Induction of Apoptosis and Potentiation of TNF- and Fas-Mediated Apoptosis in U937 Cells by the Xanthogenate Compound D609. Experimental Cell Research 1997;235:48-54. [DOI: 10.1006/excr.1997.3641] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
152 Cook AB, Ziazadeh DR, Lu J, Jackson TL. An integrated cellular and sub-cellular model of cancer chemotherapy and therapies that target cell survival. Math Biosci Eng 2015;12:1219-35. [PMID: 26775858 DOI: 10.3934/mbe.2015.12.1219] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
153 Previati M, Lanzoni I, Corbacella E, Magosso S, Giuffrè S, Francioso F, Arcelli D, Volinia S, Barbieri A, Hatzopoulos S, Capitani S, Martini A. RNA expression induced by cisplatin in an organ of Corti-derived immortalized cell line. Hearing Research 2004;196:8-18. [DOI: 10.1016/j.heares.2004.04.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
154 Duverger V, Sartorius U, Klein-bauernschmitt P, Krammer PH, Schlehofer JR. Enhancement of cisplatin-induced apoptosis by infection with adeno-associated virus type 2. Int J Cancer 2002;97:706-12. [DOI: 10.1002/ijc.10077] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
155 Jäckel MC, Tausch-Treml R, Köpf-Maier P. Cytokinetic effects of cisplatin on diverse human head and neck carcinomas in vitro: dependence on the tumor sensitivity to cisplatin. J Cancer Res Clin Oncol 1996;122:596-602. [PMID: 8879257 DOI: 10.1007/BF01221191] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
156 Otto AM. Combinations of interferon with platinum complexes: synergistic and antagonistic effects on growth inhibition of MCF-7 and MDA-MB231 breast cancer cells. J Cancer Res Clin Oncol 1994;120:286-92. [DOI: 10.1007/bf01236385] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
157 Kosmider B, Wyszynska K, Janik-spiechowicz E, Osiecka R, Zyner E, Ochocki J, Ciesielska E, Wasowicz W. Evaluation of the genotoxicity of cis-bis(3-aminoflavone)dichloroplatinum(II) in comparison with cis-DDP. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2004;558:93-110. [DOI: 10.1016/j.mrgentox.2003.11.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
158 Rey J, Scott R, Müller H. Apoptosis is not involved in the hypersensitivity of fanconi anemia cells to mitomycin C. Cancer Genetics and Cytogenetics 1994;75:67-71. [DOI: 10.1016/0165-4608(94)90218-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
159 Cohen SM, Lippard SJ. Cisplatin: from DNA damage to cancer chemotherapy. Prog Nucleic Acid Res Mol Biol. 2001;67:93-130. [PMID: 11525387 DOI: 10.1016/s0079-6603(01)67026-0] [Cited by in Crossref: 379] [Cited by in F6Publishing: 121] [Article Influence: 19.0] [Reference Citation Analysis]
160 Fox ME, Feldman BJ, Chu G. A novel role for DNA photolyase: binding to DNA damaged by drugs is associated with enhanced cytotoxicity in Saccharomyces cerevisiae. Mol Cell Biol 1994;14:8071-7. [PMID: 7969145 DOI: 10.1128/mcb.14.12.8071-8077.1994] [Cited by in Crossref: 32] [Article Influence: 1.2] [Reference Citation Analysis]
161 Orlandi L, Zaffaroni N, Bearzatto A, Costa A, Supino R, Vaglini M, Silvestrini R. Effect of melphalan and hyperthermia on cell cycle progression and cyclin B 1 expression in human melanoma cells. Cell Prolif 1995;28:617-30. [DOI: 10.1111/j.1365-2184.1995.tb00049.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
162 Meseda CA, Arrand JR, Mackett M. Herpesvirus papio encodes a functional homologue of the Epstein–Barr virus apoptosis suppressor, BHRF1. Microbiology 2000;81:1801-5. [DOI: 10.1099/0022-1317-81-7-1801] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
163 Li QQ, Wang G, Huang F, Li JM, Cuff CF, Reed E. Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogs. Med Oncol 2013;30:488. [PMID: 23397083 DOI: 10.1007/s12032-013-0488-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
164 Salm F, Cwiek P, Ghosal A, Lucia Buccarello A, Largey F, Wotzkow C, Höland K, Styp-Rekowska B, Djonov V, Zlobec I, Bodmer N, Gross N, Westermann F, Schäfer SC, Arcaro A. RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance. Oncogene 2013;32:3944-53. [PMID: 23027129 DOI: 10.1038/onc.2012.416] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
165 Minagawa Y, Kigawa J, Itamochi H, Kanamori Y, Shimada M, Takahashi M, Terakawa N. Cisplatin-resistant HeLa cells are resistant to apoptosis via p53-dependent and -independent pathways. Jpn J Cancer Res 1999;90:1373-9. [PMID: 10665656 DOI: 10.1111/j.1349-7006.1999.tb00722.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
166 Hamaguchi N, Hamada H, Miyoshi S, Irifune K, Ito R, Miyazaki T, Higaki J. In vitro and in vivo therapeutic efficacy of the PPAR-γ agonist troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth. Cancer Sci 2010;101:1955-64. [PMID: 20608936 DOI: 10.1111/j.1349-7006.2010.01632.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
167 Costa-Silva HM, Resende BC, Umaki ACS, Prado W, da Silva MS, Virgílio S, Macedo AM, Pena SDJ, Tahara EB, Tosi LRO, Elias MC, Andrade LO, Reis-Cunha JL, Franco GR, Fragoso SP, Machado CR. DNA Topoisomerase 3α Is Involved in Homologous Recombination Repair and Replication Stress Response in Trypanosoma cruzi. Front Cell Dev Biol 2021;9:633195w. [PMID: 34055812 DOI: 10.3389/fcell.2021.633195] [Reference Citation Analysis]
168 Thomas C, Ammar A, Farrell J, Elsaleh H. Radiation Modifiers: Treatment Overview and Future Investigations. Hematology/Oncology Clinics of North America 2006;20:119-39. [DOI: 10.1016/j.hoc.2006.01.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
169 Marcu L, Bezak E. Stochastic modelling of the role of cisplatin in altered fractionation schedules for head and neck cancer. Phys Med 2010;26:177-83. [PMID: 20034829 DOI: 10.1016/j.ejmp.2009.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
170 Little SA, Mirkes PE. Effects of 4-hydroperoxycyclophosphamide (4-OOH-CP) and 4-hydroperoxydechlorocyclophosphamide (4-OOH-deCICP) on the cell cycle of post implantation rat embryos. Teratology 1992;45:163-73. [DOI: 10.1002/tera.1420450210] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
171 Fearnhead HO, Rivett A, Dinsdale D, Cohen GM. A pre-existing protease is a common effector of thymocyte apoptosis mediated by diverse stimuli. FEBS Letters 1995;357:242-6. [DOI: 10.1016/0014-5793(94)01367-a] [Cited by in Crossref: 34] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
172 Lee PS, Fang J, Jessop L, Myers T, Raj P, Hu N, Wang C, Taylor PR, Wang J, Khan J, Jasin M, Chanock SJ. RAD51B Activity and Cell Cycle Regulation in Response to DNA Damage in Breast Cancer Cell Lines. Breast Cancer (Auckl) 2014;8:135-44. [PMID: 25368520 DOI: 10.4137/BCBCR.S17766] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
173 Marissen WE, Lloyd RE. Eukaryotic translation initiation factor 4G is targeted for proteolytic cleavage by caspase 3 during inhibition of translation in apoptotic cells. Mol Cell Biol 1998;18:7565-74. [PMID: 9819442 DOI: 10.1128/MCB.18.12.7565] [Cited by in Crossref: 149] [Cited by in F6Publishing: 68] [Article Influence: 6.5] [Reference Citation Analysis]
174 Babolmorad G, Latif A, Domingo IK, Pollock NM, Delyea C, Rieger AM, Allison WT, Bhavsar AP. Toll-like receptor 4 is activated by platinum and contributes to cisplatin-induced ototoxicity. EMBO Rep 2021;22:e51280. [PMID: 33733573 DOI: 10.15252/embr.202051280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
175 Ubol S, Park S, Budihardjo I, Desnoyers S, Montrose MH, Poirier GG, Kaufmann SH, Griffin DE. Temporal changes in chromatin, intracellular calcium, and poly(ADP-ribose) polymerase during Sindbis virus-induced apoptosis of neuroblastoma cells. J Virol 1996;70:2215-20. [DOI: 10.1128/jvi.70.4.2215-2220.1996] [Cited by in Crossref: 40] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
176 Emura I, Chou T, Imai Y, Kakihar T, Ishiguro T, Naito M, Yoshizawa H, Arakawa M. Overexpression of heat shock protein 60 and the survival of blast in acute myeloid leukemia after induction therapy. Leukemia 2000;14:1529-30. [DOI: 10.1038/sj.leu.2401857] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
177 Kang FC, Chen PJ, Pan BS, Lai MS, Chen YC, Huang BM. Apoptotic effect of cordycepin combined with cisplatin and/or paclitaxel on MA-10 mouse Leydig tumor cells. Onco Targets Ther 2015;8:2345-60. [PMID: 26366090 DOI: 10.2147/OTT.S87010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
178 Pérez JM, Quiroga AG, Montero EI, Alonso C, Navarro-ranninger C. A cycloplatinated compound of p-isopropylbenzaldehyde thiosemicarbazone and its chloro-bridged derivative induce apoptosis in cis-DDP resistant cells which overexpress the H-ras oncogene. Journal of Inorganic Biochemistry 1999;73:235-43. [DOI: 10.1016/s0162-0134(99)00021-5] [Cited by in Crossref: 16] [Article Influence: 0.7] [Reference Citation Analysis]
179 Falcieri E, Gobbi P, Cataldi A, Zamai L, Faenza I, Vitale M. Nuclear pores in the apoptotic cell. Histochem J 1994;26:754-63. [PMID: 7843986 DOI: 10.1007/BF00158206] [Cited by in Crossref: 41] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
180 Bodek G, Kowalczyk A, Waclawik A, Huhtaniemi I, Ziecik AJ. Targeted ablation of prostate carcinoma cells through LH receptor using Hecate-CGbeta conjugate: functional characteristic and molecular mechanism of cell death pathway. Exp Biol Med (Maywood) 2005;230:421-8. [PMID: 15956772 DOI: 10.1177/15353702-0323006-10] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
181 Schröder CP, Godwin AK, O'dwyer PJ, Tew KD, Hamilton TC, Ozols RF. Glutathione and Drug Resistance. Cancer Investigation 2009;14:158-68. [DOI: 10.3109/07357909609018891] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
182 Mello JA, Acharya S, Fishel R, Essigmann JM. The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem Biol. 1996;3:579-589. [PMID: 8807890 DOI: 10.1016/s1074-5521(96)90149-0] [Cited by in Crossref: 124] [Cited by in F6Publishing: 45] [Article Influence: 5.2] [Reference Citation Analysis]
183 Yasunaga M, Tabira Y, Kondo K, Okuma T, Kitamura N. The prognostic significance of cell cycle markers in esophageal cancer after neoadjuvant chemotherapy. Dis Esophagus 1999;12:120-7. [PMID: 10466044 DOI: 10.1046/j.1442-2050.1999.00031.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
184 Bodiga VL, Bodiga S, Surampudi S, Boindala S, Putcha U, Nagalla B, Subramaniam K, Manchala R. Effect of vitamin supplementation on cisplatin-induced intestinal epithelial cell apoptosis in Wistar/NIN rats. Nutrition 2012;28:572-80. [PMID: 22189195 DOI: 10.1016/j.nut.2011.09.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
185 O'brien BA, Harmon BV, Cameron DP, Allan DJ. BETA-CELL APOPTOSIS IS RESPONSIBLE FOR THE DEVELOPMENT OF IDDM IN THE MULTIPLE LOW-DOSE STREPTOZOTOCIN MODEL. J Pathol 1996;178:176-81. [DOI: 10.1002/(sici)1096-9896(199602)178:2<176::aid-path433>3.0.co;2-8] [Cited by in Crossref: 134] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
186 Takayama S, Cazals-hatem DL, Kitada S, Tanaka S, Miyashita T, Hovey LR, Huen D, Rickinson A, Veerapandian P, Krajewski S, Saito K, Reed JC. Evolutionary Conservation of Function Among Mammalian, Avian, and Viral Homologs of the Bcl-2 Oncoprotein. DNA and Cell Biology 1994;13:679-92. [DOI: 10.1089/dna.1994.13.679] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.2] [Reference Citation Analysis]
187 Dedoussis GV, Mouzaki A, Theodoropoulou M, Menounos P, Kyrtsonis M, Karameris A, Maniatis A. Endogenous Interleukin 6 Conveys Resistance to cis-Diamminedichloroplatinum-Mediated Apoptosis of the K562 Human Leukemic Cell Line. Experimental Cell Research 1999;249:269-78. [DOI: 10.1006/excr.1999.4442] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
188 Marcu LG. Tumour repopulation and the role of abortive division in squamous cell carcinomas during chemotherapy. Cell Prolif 2014;47:318-25. [PMID: 24824866 DOI: 10.1111/cpr.12108] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
189 Jakupec MA, Galanski M, Keppler BK. Tumour-inhibiting platinum complexes—state of the art and future perspectives. Reviews of Physiology, Biochemistry and Pharmacology. Berlin: Springer Berlin Heidelberg; 2003. pp. 1-53. [DOI: 10.1007/s10254-002-0001-x] [Cited by in Crossref: 304] [Cited by in F6Publishing: 264] [Reference Citation Analysis]
190 Xiao-ming S, Dinsdale D, Snowden RT, Cohen GM, Skilleter DN. Characterization of apoptosis in thymocytes isolated from dexamethasone-treated rats. Biochemical Pharmacology 1992;44:2131-7. [DOI: 10.1016/0006-2952(92)90339-k] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
191 Ormerod MG, Orr RM, Peacock JH. The role of apoptosis in cell killing by cisplatin: a flow cytometric study. Br J Cancer 1994;69:93-100. [PMID: 8286217 DOI: 10.1038/bjc.1994.14] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 3.1] [Reference Citation Analysis]
192 Holmström TH, Tran SE, Johnson VL, Ahn NG, Chow SC, Eriksson JE. Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis. Mol Cell Biol 1999;19:5991-6002. [PMID: 10454546 DOI: 10.1128/MCB.19.9.5991] [Cited by in Crossref: 75] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
193 Krishnaswamy G, Dewey WC. Cisplatin induced cell killing and chromosomal aberrations in CHO cells: treated during G1 or S phase. Mutation Research/DNA Repair 1993;293:161-72. [DOI: 10.1016/0921-8777(93)90067-q] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
194 Chintala SK, Ali-Osman F, Mohanam S, Rayford A, Go Y, Gokaslan ZL, Gagercas E, Venkaiah B, Sawaya R, Nicolson GL, Rao JS. Effect of cisplatin and BCNU on MMP-2 levels in human glioblastoma cell lines in vitro. Clin Exp Metastasis 1997;15:361-7. [PMID: 9219724 DOI: 10.1023/a:1018442003163] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
195 Wang Y, Luo Z, Pan Y, Wang W, Zhou X, Jeong LS, Chu Y, Liu J, Jia L. Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells. Cancer Biol Ther 2015;16:420-9. [PMID: 25782162 DOI: 10.1080/15384047.2014.1003003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
196 Holme JA, Wiger R, Hongslo JK, Søderlund EJ, Brunborg G, Dybing E. Cell Death via Interactions of Agents with DNA. Mechanisms of Cell Toxicity. Elsevier; 1997. pp. 145-82. [DOI: 10.1016/s1569-2558(08)60274-x] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
197 Vijayalakshmi B, Sesikeran B, Udaykumar P, Kalyanasundaram S, Raghunath M. Chronic low vitamin intake potentiates cisplatin-induced intestinal epithelial cell apoptosis in WNIN rats. World J Gastroenterol 2006; 12(7): 1078-1085 [PMID: 16534849 DOI: 10.3748/wjg.v12.i7.1078] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
198 Fajao A, Da Silva J, Ahomadegbe J, Rateau J, Bernaudin J, Riou G, Bénard J. Cisplatin-induced apoptosis andp53 gene status in a cisplatin-resistant human ovarian carcinoma cell line. Int J Cancer 1996;68:67-74. [DOI: 10.1002/(sici)1097-0215(19960927)68:1<67::aid-ijc13>3.0.co;2-3] [Cited by in Crossref: 41] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
199 Takemura K, Noguchi M, Ogi K, Tokino T, Kubota H, Miyazaki A, Kohama G, Hiratsuka H. Enhanced Bax in oral SCC in relation to antitumor effects of chemotherapy. J Oral Pathol Med 2005;34:93-9. [DOI: 10.1111/j.1600-0714.2004.00257.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
200 Evans GL, Gralla JD. Differential effects of cisplatin on the expression of chimeric marker genes in CV-1 cells. Biochemical Pharmacology 1992;44:107-19. [DOI: 10.1016/0006-2952(92)90044-j] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
201 Chao JC, Steven Wan X, Engelsberg BN, Rothblum LI, Billings PC. Intracellular distribution of HMG1, HMG2 and UBF change following treatment with cisplatin. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1996;1307:213-9. [DOI: 10.1016/0167-4781(96)00052-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
202 Lee JW, Lee S, Ho J, Youn J, Byun S, Lee E. Antitumor effects of MutT homolog 1 inhibitors in human bladder cancer cells. Bioscience, Biotechnology, and Biochemistry 2019;83:2265-71. [DOI: 10.1080/09168451.2019.1648207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
203 Meyn RE, Stephens LC, Hunter NR, Milas L. Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas. Int J Cancer. 1995;60:725-729. [PMID: 7860148 DOI: 10.1002/ijc.2910600526] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 1.3] [Reference Citation Analysis]
204 Veena MS, Wilken R, Zheng JY, Gholkar A, Venkatesan N, Vira D, Ahmed S, Basak SK, Dalgard CL, Ravichandran S, Batra RK, Kasahara N, Elashoff D, Fishbein MC, Whitelegge JP, Torres JZ, Wang MB, Srivatsan ES. p16 Protein and gigaxonin are associated with the ubiquitination of NFκB in cisplatin-induced senescence of cancer cells. J Biol Chem 2014;289:34921-37. [PMID: 25331947 DOI: 10.1074/jbc.M114.568543] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
205 Dias-baruffi M, Zhu H, Cho M, Karmakar S, Mcever RP, Cummings RD. Dimeric Galectin-1 Induces Surface Exposure of Phosphatidylserine and Phagocytic Recognition of Leukocytes without Inducing Apoptosis. Journal of Biological Chemistry 2003;278:41282-93. [DOI: 10.1074/jbc.m306624200] [Cited by in Crossref: 119] [Cited by in F6Publishing: 51] [Article Influence: 6.6] [Reference Citation Analysis]
206 Borner MM, Joncourt F, Hotz MA. Similarity of apoptosis induction by 2-chlorodeoxyadenosine and cisplatin in human mononuclear blood cells. Br J Cancer 1997;76:1448-54. [PMID: 9400941 DOI: 10.1038/bjc.1997.577] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
207 Eastman A, Barry MA, Demarcq C. The Involvement of the Cell Cycle in Apoptosis. In: Hu VW, editor. The Cell Cycle. Boston: Springer US; 1994. pp. 369-78. [DOI: 10.1007/978-1-4615-2421-2_43] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
208 Demarcq C, Bastian G, Remvikos Y. BrdUrd/DNA flow cytometry analysis demonstrates cis-diamminedichloroplatinum (II)-induced multiple cell-cycle modifications on human lung carcinoma cells. Cytometry 1992;13:416-22. [PMID: 1526199 DOI: 10.1002/cyto.990130412] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
209 Henklewska M, Pawlak A, Kutkowska J, Pruchnik H, Rapak A, Obminska-Mrukowicz B. In vitro effects of the activity of novel platinum (II) complex in canine and human cell lines. Vet Comp Oncol 2019;17:497-506. [PMID: 31111625 DOI: 10.1111/vco.12511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
210 Eastman A. The Interaction of Cisplatin with Signal Transduction Pathways and the Regulation of Apoptosis. In: Pinedo HM, Schornagel JH, editors. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2. Boston: Springer US; 1996. pp. 283-91. [DOI: 10.1007/978-1-4899-0218-4_26] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
211 Carminati PO, Mello SS, Fachin AL, Junta CM, Sandrin-Garcia P, Carlotti CG, Donadi EA, Passos GA, Sakamoto-Hojo ET. Alterations in gene expression profiles correlated with cisplatin cytotoxicity in the glioma U343 cell line. Genet Mol Biol 2010;33:159-68. [PMID: 21637621 DOI: 10.1590/S1415-47572010005000013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
212 Leung AW, Dragowska WH, Ricaurte D, Kwok B, Mathew V, Roosendaal J, Ahluwalia A, Warburton C, Laskin JJ, Stirling PC, Qadir MA, Bally MB. 3'-Phosphoadenosine 5'-phosphosulfate synthase 1 (PAPSS1) knockdown sensitizes non-small cell lung cancer cells to DNA damaging agents. Oncotarget 2015;6:17161-77. [PMID: 26220590 DOI: 10.18632/oncotarget.3635] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
213 Collins MKL, Perkins GR, Rodriguez-tarduchy G, Nieto MA, López-rivas A. Growth factors as survival factors: Regulation of apoptosis: Growth Factors as Survival Factors. Bioessays 1994;16:133-8. [DOI: 10.1002/bies.950160210] [Cited by in Crossref: 124] [Cited by in F6Publishing: 113] [Article Influence: 7.8] [Reference Citation Analysis]
214 Sato PH, Rosenberg JM, Sato RI. Differences in the inhibition of translation by cisplatin, transplatin, and certain related compounds. Biochemical Pharmacology 1996;52:1895-902. [DOI: 10.1016/s0006-2952(96)00663-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
215 Itoh M, Chiba H, Noutomi T, Takada E, Mizuguchi J. Cleavage of Bax-α and Bcl-xL during carboplatin-mediated apoptosis in squamous cell carcinoma cell line. Oral Oncology 2000;36:277-85. [DOI: 10.1016/s1368-8375(00)00010-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
216 Alshatwi AA, Athinarayanan J, Vaiyapuri Subbarayan P. Green synthesis of platinum nanoparticles that induce cell death and G2/M-phase cell cycle arrest in human cervical cancer cells. J Mater Sci Mater Med 2015;26:5330. [PMID: 25577212 DOI: 10.1007/s10856-014-5330-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 7.5] [Reference Citation Analysis]
217 O’connor PM, Fan S. DNA damage checkpoints: Implications for cancer therapy. In: Meijer L, Guidet S, Vogel L, editors. Progress in Cell Cycle Research. Boston: Springer US; 1996. pp. 165-73. [DOI: 10.1007/978-1-4615-5873-6_16] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 1.4] [Reference Citation Analysis]
218 Barnes CJ, Wahl AF, Shen B, Park MS, Bambara RA. Mechanism of Tracking and Cleavage of Adduct-damaged DNA Substrates by the Mammalian 5′- to 3′-Exonuclease/Endonuclease RAD2 Homologue 1 or Flap Endonuclease 1. Journal of Biological Chemistry 1996;271:29624-31. [DOI: 10.1074/jbc.271.47.29624] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 1.2] [Reference Citation Analysis]
219 Nakamoto S. An interaction of cis platin and radiation in two rat yolk sac tumour cell lines with different radiosensitivities in vitro. International Journal of Radiation Biology 2009;70:747-53. [DOI: 10.1080/095530096144635] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
220 O'reilly S, Rowinsky EK. The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue: 1996. Critical Reviews in Oncology/Hematology 1996;24:47-70. [DOI: 10.1016/1040-8428(96)00211-9] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 1.8] [Reference Citation Analysis]
221 Yin D, Kondo S, Barnett GH, Morimura T, Takeuchi J. Tumor Necrosis Factor-α Induces p53-dependent Apoptosis in Rat Glioma Cells. Neurosurgery 1995;37:758-63. [DOI: 10.1227/00006123-199510000-00021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
222 Tsuchida E, Urano M. The effect of UCN-01 (7-hydroxystaurosporine), a potent inhibitor of protein kinase C, on fractionated radiotherapy or daily chemotherapy of a murine fibrosarcoma. International Journal of Radiation Oncology*Biology*Physics 1997;39:1153-61. [DOI: 10.1016/s0360-3016(97)00549-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
223 Benedetti M, Malina J, Kasparkova J, Brabec V, Natile G. Chiral discrimination in platinum anticancer drugs. Environ Health Perspect 2002;110 Suppl 5:779-82. [PMID: 12426131 DOI: 10.1289/ehp.02110s5779] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.3] [Reference Citation Analysis]
224 Freund A, Boos J, Harkin S, Schultze-Mosgau M, Veerman G, Peters GJ, Gescher A. Augmentation of 1-beta-D-arabinofuranosylcytosine (Ara-C) cytotoxicity in leukaemia cells by co-administration with antisignalling drugs. Eur J Cancer 1998;34:895-901. [PMID: 9797704 DOI: 10.1016/s0959-8049(97)10149-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
225 Gupta R, Beck JL, Sheil MM, Ralph SF. Identification of bifunctional GA and AG intrastrand crosslinks formed between cisplatin and DNA. J Inorg Biochem 2005;99:552-9. [PMID: 15621289 DOI: 10.1016/j.jinorgbio.2004.11.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
226 Erba E, Mascellani E, Pifferi A, D'incalci M. Comparison of cell-cycle phase perturbations induced by the DNA-minor-groove alkylator tallimustine and by melphalan in the SW626 cell line. Int J Cancer 1995;62:170-5. [DOI: 10.1002/ijc.2910620211] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
227 Mariggiò MA, Cafaggi S, Ottone M, Parodi B, Vannozzi MO, Mandys V, Viale M. Inhibition of cell growth, induction of apoptosis and mechanism of action of the novel platinum compound cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N(4)]-chloride platinum (II) monohydrochloride monohydrate. Invest New Drugs. 2004;22:3-16. [PMID: 14707490 DOI: 10.1023/b:drug.0000006170.38419.c9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
228 Siegel RM, Katsumata M, Miyashita T, Louie DC, Greene MI, Reed JC. Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Proc Natl Acad Sci U S A 1992;89:7003-7. [PMID: 1495993 DOI: 10.1073/pnas.89.15.7003] [Cited by in Crossref: 103] [Cited by in F6Publishing: 101] [Article Influence: 3.6] [Reference Citation Analysis]
229 Lin-Chao S, Chao CC. Reduced Inhibition of DNA Synthesis and G(2) Arrest during the Cell Cycle of Resistant HeLa Cells in Response to cis-Diamminedichloroplatinum. J Biomed Sci 1994;1:131-8. [PMID: 11725016 DOI: 10.1007/BF02257987] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
230 Nishio K, Sugimoto Y, Fujiwara Y, Ohmori T, Morikage T, Takeda Y, Ohata M, Saijo N. Phospholipase C-mediated hydrolysis of phosphatidylcholine is activated by cis-diamminedichloroplatinum(II). J Clin Invest 1992;89:1622-8. [PMID: 1569201 DOI: 10.1172/JCI115758] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
231 MacKeigan JP, Murphy LO, Blenis J. Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat Cell Biol. 2005;7:591-600. [PMID: 15864305 DOI: 10.1038/ncb1258] [Cited by in Crossref: 388] [Cited by in F6Publishing: 363] [Article Influence: 24.3] [Reference Citation Analysis]
232 Fearnhead HO, Dinsdale D, Cohen GM. An interleukin-1β-converting enzyme-like protease is a common mediator of apoptosis in thymocytes. FEBS Letters 1995;375:283-8. [DOI: 10.1016/0014-5793(95)01228-7] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 3.1] [Reference Citation Analysis]
233 Sun X, Ross D. Quinone-induced apoptosis in human colon adenocarcinoma cells via DT-diaphorase mediated bioactivation. Chemico-Biological Interactions 1996;100:267-76. [DOI: 10.1016/0009-2797(96)03704-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
234 Sirzén F, Zhivotovsky B, Nilsson A, Bergh J, Lewensohn R. Higher spontaneous apoptotic index in small cell compared with non-small cell lung carcinoma cell lines; lack of correlation with Bcl-2/Bax. Lung Cancer. 1998;22:1-13. [PMID: 9869102 DOI: 10.1016/S0169-5002(98)00066-X] [Cited by in Crossref: 30] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
235 Erenpreisa J, Roach HI. Epigenetic selection as a possible component of transdifferentiation. Further study of the commitment of hypertrophic chondrocytes to become osteocytes. Mechanisms of Ageing and Development 1996;87:165-82. [DOI: 10.1016/0047-6374(96)01703-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
236 Hägerlöf M, Papsai P, Chow CS, Elmroth SK. More pronounced salt dependence and higher reactivity for platination of the hairpin r(CGCGUUGUUCGCG) compared with d(CGCGTTGTTCGCG). J Biol Inorg Chem 2006;11:974-90. [PMID: 16953416 DOI: 10.1007/s00775-006-0157-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
237 李敏, 王志举, 李文涛, 董子明. 人食管癌顺铂耐药细胞系Ec9706/cDDP的建立及其生物学特征. 世界华人消化杂志 2006; 14(34): 3257-3260 [DOI: 10.11569/wcjd.v14.i34.3257] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
238 Kobayashi K, Tsukamoto I. Prolonged Jun N-terminal kinase (JNK) activation and the upregulation of p53 and p21(WAF1/CIP1) preceded apoptosis in hepatocytes after partial hepatectomy and cisplatin. Biochim Biophys Acta 2001;1537:79-88. [PMID: 11476966 DOI: 10.1016/s0925-4439(01)00059-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
239 Ma L, Yan H, Zhou Q. AG1478 inhibits the migration and invasion of cisplatin-resistant human lung adenocarcinoma cells via the cell cycle regulation by matrix metalloproteinase-9. Oncol Lett 2014;8:921-7. [PMID: 25009665 DOI: 10.3892/ol.2014.2224] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
240 Sakai S, Izumi H, Yoshiura Y, Nakayama Y, Yamaguchi T, Harada Y, Koi C, Kurata H, Morimoto Y. In vitro evaluation of a combination treatment involving anticancer agents and an aurora kinase B inhibitor. Oncol Lett 2016;12:4263-9. [PMID: 27895801 DOI: 10.3892/ol.2016.5156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
241 Jirsová K, Mandys V. Induction of micronuclei and granular chromatin condensation in human skin fibroblasts influenced by cisplatin (cis-DDP) in vitro. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1994;310:37-44. [DOI: 10.1016/0027-5107(94)90006-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
242 Abás E, Bellés A, Rodríguez-Diéguez A, Laguna M, Grasa L. Selective cytotoxicity of cyclometalated gold(III) complexes on Caco-2 cells is mediated by G2/M cell cycle arrest. Metallomics 2021;13:mfab034. [PMID: 34114030 DOI: 10.1093/mtomcs/mfab034] [Reference Citation Analysis]
243 Freund A, Rössig C, Lanvers C, Gescher A, Hohenlöchter B, Jürgens H, Boos J. All-trans-retinoic acid increases cytosine arabinoside cytotoxicity in HL-60 human leukemia cells in spite of decreased cellular ara-CTP accumulation. Ann Oncol 1999;10:335-8. [PMID: 10355579 DOI: 10.1023/a:1008365714942] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
244 Baffy G, Miyashita T, Williamson J, Reed J. Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. Journal of Biological Chemistry 1993;268:6511-9. [DOI: 10.1016/s0021-9258(18)53280-4] [Cited by in Crossref: 253] [Article Influence: 9.0] [Reference Citation Analysis]
245 Bottone MG, Soldani C, Veneroni P, Avella D, Pisu M, Bernocchi G. Cell proliferation, apoptosis and mitochondrial damage in rat B50 neuronal cells after cisplatin treatment. Cell Prolif 2008;41:506-20. [PMID: 18397337 DOI: 10.1111/j.1365-2184.2008.00530.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
246 William-faltaos S, Rouillard D, Lechat P, Bastian G. Cell cycle arrest by oxaliplatin on cancer cells. Fundam Clin Pharmacol 2007;21:165-72. [DOI: 10.1111/j.1472-8206.2007.00462.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
247 García-Moreno E, Tomás A, Atrián-Blasco E, Gascón S, Romanos E, Rodriguez-Yoldi MJ, Cerrada E, Laguna M. In vitro and in vivo evaluation of organometallic gold(I) derivatives as anticancer agents. Dalton Trans 2016;45:2462-75. [PMID: 26469679 DOI: 10.1039/c5dt01802a] [Cited by in Crossref: 31] [Cited by in F6Publishing: 6] [Article Influence: 5.2] [Reference Citation Analysis]
248 Freeburg EM, Goyeneche AA, Telleria CM. Mifepristone abrogates repopulation of ovarian cancer cells in between courses of cisplatin treatment. Int J Oncol 2009;34:743-55. [PMID: 19212679 DOI: 10.3892/ijo_00000200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 0.1] [Reference Citation Analysis]
249 Taudou G, Portemer C, Jaxel C, Duguet M. Inhibition of DNA synthesis and DNA fragmentation in stimulated splenocytes by the concerted action of topoisomerase I and II poisons. Biochem Pharmacol 1993;45:331-7. [PMID: 8382059 DOI: 10.1016/0006-2952(93)90068-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
250 Dedoussis GV, Andrikopoulos NK. Glutathione depletion restores the susceptibility of cisplatin-resistant chronic myelogenous leukemia cell lines to Natural Killer cell-mediated cell death via necrosis rather than apoptosis. Eur J Cell Biol. 2001;80:608-614. [PMID: 11675936 DOI: 10.1078/0171-9335-00193] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
251 Wesierska-Gadek J, Wandl S, Kramer MP, Pickem C, Krystof V, Hajek SB. Roscovitine up-regulates p53 protein and induces apoptosis in human HeLaS(3) cervix carcinoma cells. J Cell Biochem. 2008;105:1161-1171. [PMID: 18846503 DOI: 10.1002/jcb.21903] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
252 Chow SC, Snowden R, Orrenius S, Cohen GM. Susceptibility of different subsets of immature thymocytes to apoptosis. FEBS Letters 1997;408:141-6. [DOI: 10.1016/s0014-5793(97)00308-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
253 Sanders EJ, Wride MA. Programmed cell death in development. Int Rev Cytol. 1995;163:105-173. [PMID: 8522419 DOI: 10.1016/s0074-7696(08)62210-x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
254 Tureček R, Mandys V, Bär P, Likovský Z. Cisplatin-induced changes in the number of argyrophilic nucleolar granules in cultured chick dorsal root ganglion neurons. Neurosci Res Comm 1996;18:185-93. [DOI: 10.1002/(sici)1520-6769(199605)18:3<185::aid-nrc155>3.0.co;2-z] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
255 Barry MA, Behnke CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol. 1990;40:2353-2362. [PMID: 2244936 DOI: 10.1016/0006-2952(90)90733-2] [Cited by in Crossref: 581] [Cited by in F6Publishing: 585] [Article Influence: 18.7] [Reference Citation Analysis]
256 Ormerod MG, O’neill C, Robertson D, Kelland LR, Harrap KR. cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines. Cancer Chemother Pharmacol 1996;37:463-71. [DOI: 10.1007/s002800050413] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 2.3] [Reference Citation Analysis]
257 Pisano M, Palomba A, Tanca A, Pagnozzi D, Uzzau S, Addis MF, Dettori MA, Fabbri D, Palmieri G, Rozzo C. Protein expression changes induced in a malignant melanoma cell line by the curcumin analogue compound D6. BMC Cancer 2016;16:317. [PMID: 27192978 DOI: 10.1186/s12885-016-2362-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
258 Koi C, Izumi H, Kurita T, Nguyen TT, Murakami M, Yoshiura Y, Hachisuga T, Morimoto Y. Lovastatin induced Kruppel like factor 2 (KLF2), Kruppel like factor 6 (KLF6) and Ras homolog family member B (RHOB) genes and preferentially led to viability reduction of Cisplatin-resistant cells. Oncotarget 2017;8:106429-42. [PMID: 29290960 DOI: 10.18632/oncotarget.22472] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
259 Iyer RR, Pluciennik A, Burdett V, Modrich PL. DNA mismatch repair: functions and mechanisms. Chem Rev. 2006;106:302-323. [PMID: 16464007 DOI: 10.1021/cr0404794] [Cited by in Crossref: 590] [Cited by in F6Publishing: 549] [Article Influence: 39.3] [Reference Citation Analysis]
260 Payne CM, Bernstein C, Bernstein H. Apoptosis overview emphasizing the role of oxidative stress, DNA damage and signal-transduction pathways. Leuk Lymphoma 1995;19:43-93. [PMID: 8574171 DOI: 10.3109/10428199509059662] [Cited by in Crossref: 109] [Cited by in F6Publishing: 103] [Article Influence: 4.4] [Reference Citation Analysis]
261 Elkady AI. Crude alkaloid extract of Rhazya stricta inhibits cell growth and sensitizes human lung cancer cells to cisplatin through induction of apoptosis. Genet Mol Biol. 2013;36:12-21. [PMID: 23569403 DOI: 10.1590/s1415-47572013005000009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
262 Eastman A. Chapter 3 Assays for DNA Fragmentation, Endonucleases, and Intracellular pH and Ca2+ Associated with Apoptosis. Cell Death. Elsevier; 1995. pp. 41-55. [DOI: 10.1016/s0091-679x(08)61923-8] [Cited by in Crossref: 84] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
263 Plunkett W, Gandhi V, Kantarjian H, Keating MJ. Pharmacologically Guided Leukemia Therapy. In: Hiddemann W, Büchner T, Wörmann B, Plunkett W, Keating M, Andreeff M, editors. Acute Leukemias. Berlin: Springer Berlin Heidelberg; 1992. pp. 253-7. [DOI: 10.1007/978-3-642-76591-9_39] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
264 Taichman RS, Torigoe T, Tanaka S, Miyashita T, Reed JC. Gene transfer investigations of p56-LCK function in IL-2-dependent T-cell lines: Implications for mechanisms of IL-2-signal transduction. Cytokine 1992;4:441-53. [DOI: 10.1016/1043-4666(92)90004-b] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
265 Dempke W, Voigt W, Grothey A, Hill BT, Schmoll HJ. Cisplatin resistance and oncogenes--a review. Anticancer Drugs. 2000;11:225-236. [PMID: 10898536 DOI: 10.1097/00001813-200004000-00001] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 3.7] [Reference Citation Analysis]
266 Marcu LG, Bezak E. Neoadjuvant cisplatin for head and neck cancer: Simulation of a novel schedule for improved therapeutic ratio. Journal of Theoretical Biology 2012;297:41-7. [DOI: 10.1016/j.jtbi.2011.12.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
267 Alhussan A, Bozdoğan EPD, Chithrani DB. Combining Gold Nanoparticles with Other Radiosensitizing Agents for Unlocking the Full Potential of Cancer Radiotherapy. Pharmaceutics 2021;13:442. [PMID: 33805917 DOI: 10.3390/pharmaceutics13040442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
268 Zhu H, Fearnhead HO, Cohen GM. An ICE-like protease is a common mediator of apoptosis induced by diverse stimuli in human monocytic THP.1 cells. FEBS Lett. 1995;374:303-308. [PMID: 7589559 DOI: 10.1016/0014-5793(95)01116-v] [Cited by in Crossref: 106] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
269 Holding JD, Lindup WE, van Laer C, Vreeburg GC, Schilling V, Wilson JA, Stell PM. Phase I trial of a cisplatin-albumin complex for the treatment of cancer of the head and neck. Br J Clin Pharmacol 1992;33:75-81. [PMID: 1540494 DOI: 10.1111/j.1365-2125.1992.tb04003.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 1.3] [Reference Citation Analysis]
270 Wade M, Allday MJ. Epstein-Barr virus suppresses a G(2)/M checkpoint activated by genotoxins. Mol Cell Biol 2000;20:1344-60. [PMID: 10648620 DOI: 10.1128/MCB.20.4.1344-1360.2000] [Cited by in Crossref: 40] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
271 Zheng YR, Suntharalingam K, Johnstone TC, Lippard SJ. Encapsulation of Pt(IV) Prodrugs within a Pt(II) Cage for Drug Delivery. Chem Sci 2015;6:1189-93. [PMID: 25621144 DOI: 10.1039/C4SC01892C] [Cited by in Crossref: 167] [Cited by in F6Publishing: 38] [Article Influence: 27.8] [Reference Citation Analysis]
272 Eastman A. Improving anticancer drug development begins with cell culture: misinformation perpetrated by the misuse of cytotoxicity assays. Oncotarget 2017;8:8854-66. [PMID: 27750219 DOI: 10.18632/oncotarget.12673] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 14.3] [Reference Citation Analysis]
273 Muraki Y, Tateishi A, Seta C, Fukuda J, Haneji T, Oya R, Ikemura K, Kobayashi N. Fas antigen expression and outcome of oral squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery 2000;29:360-5. [DOI: 10.1016/s0901-5027(00)80053-3] [Cited by in Crossref: 18] [Article Influence: 0.9] [Reference Citation Analysis]
274 Kirveskari J, He Q, Holmstr�m T, Leirisalo-repo M, Wuorela M, Mertsola J, Granfors K. Modulation of peripheral blood mononuclear cell activation status duringsalmonella-triggered reactive arthritis. Arthritis & Rheumatism 1999;42:2045-54. [DOI: 10.1002/1529-0131(199910)42:10<2045::aid-anr4>3.0.co;2-e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
275 Hettinga JVE, Konings AWT, Kampinga HH. Reduction of cellular cisplatin resistance by hyperthermia—a review. International Journal of Hyperthermia 2009;13:439-57. [DOI: 10.3109/02656739709023545] [Cited by in Crossref: 77] [Cited by in F6Publishing: 55] [Article Influence: 6.4] [Reference Citation Analysis]
276 Barr MP, Gray SG, Hoffmann AC, Hilger RA, Thomale J, O'Flaherty JD, Fennell DA, Richard D, O'Leary JJ, O'Byrne KJ. Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature. PLoS One 2013;8:e54193. [PMID: 23349823 DOI: 10.1371/journal.pone.0054193] [Cited by in Crossref: 158] [Cited by in F6Publishing: 153] [Article Influence: 19.8] [Reference Citation Analysis]
277 Grunicke H, Hofmann J. Cytotoxic and cytostatic effects of antitumor agents induced at the plasma membrane level. Pharmacology & Therapeutics 1992;55:1-30. [DOI: 10.1016/0163-7258(92)90027-w] [Cited by in Crossref: 31] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
278 Strojan P, Petri?-grabnar G, ?upa?i? N, Jereb B. Concomitant chemoradiotherapy for incompletely resected supratentorial low-grade astrocytoma in children: Preliminary report. Med Pediatr Oncol 1999;32:112-6. [DOI: 10.1002/(sici)1096-911x(199902)32:2<112::aid-mpo8>3.0.co;2-r] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
279 Nakada S, Aoki D, Ohie S, Horiuchi M, Suzuki N, Kanasugi M, Susumu N, Udagawa Y, Nozawa S. Chemosensitivity testing of ovarian cancer using the histoculture drug response assay: sensitivity to cisplatin and clinical response. Int J Gynecol Cancer 2005;15:445-52. [PMID: 15882168 DOI: 10.1111/j.1525-1438.2005.15307.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
280 Calsou P, Frit P, Salles B. Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts. Nucleic Acids Res 1992;20:6363-8. [PMID: 1475197 DOI: 10.1093/nar/20.23.6363] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 0.8] [Reference Citation Analysis]
281 Marcu L, Bezak E, Olver I. Scheduling cisplatin and radiotherapy in the treatment of squamous cell carcinomas of the head and neck: a modelling approach. Phys Med Biol 2006;51:3625-37. [DOI: 10.1088/0031-9155/51/15/002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
282 Wrasidlo W, Johnson DS, Boger DL. Induction of endonucleolytic DNA fragmentation and apoptosis by the duocarmycins. Bioorganic & Medicinal Chemistry Letters 1994;4:631-6. [DOI: 10.1016/s0960-894x(01)80168-2] [Cited by in Crossref: 33] [Article Influence: 1.2] [Reference Citation Analysis]
283 Todd RC, Lippard SJ. Inhibition of transcription by platinum antitumor compounds. Metallomics. 2009;1:280-291. [PMID: 20046924 DOI: 10.1039/b907567d] [Cited by in Crossref: 367] [Cited by in F6Publishing: 335] [Article Influence: 36.7] [Reference Citation Analysis]
284 Mello JA, Trimmer EE, Kartalou M, Essigmann JM. Conflicting Roles of Mismatch and Nucleotide Excision Repair in Cellular Susceptibility to Anticancer Drugs. In: Eckstein F, Lilley DMJ, editors. DNA Repair. Berlin: Springer Berlin Heidelberg; 1998. pp. 249-74. [DOI: 10.1007/978-3-642-48770-5_11] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
285 Ise T, Shimizu T, Lee EL, Inoue H, Kohno K, Okada Y. Roles of volume-sensitive Cl- channel in cisplatin-induced apoptosis in human epidermoid cancer cells. J Membr Biol 2005;205:139-45. [PMID: 16362502 DOI: 10.1007/s00232-005-0779-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
286 Suttie SA, Park KG, Smith TA. [18F]2-fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil. Br J Cancer 2007;97:902-9. [PMID: 17848947 DOI: 10.1038/sj.bjc.6603971] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
287 Lamb J, Wheatley DN. Cell killing by the novel imidazoacridinone antineoplastic agent, C-1311, is inhibited at high concentrations coincident with dose-differentiated cell cycle perturbation. Br J Cancer 1996;74:1359-68. [PMID: 8912530 DOI: 10.1038/bjc.1996.550] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
288 Sauthoff H, Heitner S, Rom WN, Hay JG. Deletion of the Adenoviral E1b-19kD Gene Enhances Tumor Cell Killing of a Replicating Adenoviral Vector. Human Gene Therapy 2000;11:379-88. [DOI: 10.1089/10430340050015851] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 3.3] [Reference Citation Analysis]
289 Piacentini M, Fesus L, Melino G. Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cells. FEBS Letters 1993;320:150-4. [DOI: 10.1016/0014-5793(93)80081-5] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 2.9] [Reference Citation Analysis]
290 Swanepoel B, Nitulescu GM, Olaru OT, Venables L, van de Venter M. Anti-Cancer Activity of a 5-Aminopyrazole Derivative Lead Compound (BC-7) and Potential Synergistic Cytotoxicity with Cisplatin against Human Cervical Cancer Cells. Int J Mol Sci 2019;20:E5559. [PMID: 31703393 DOI: 10.3390/ijms20225559] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
291 Brötz E, Herrmann J, Wiese J, Zinecker H, Maier A, Kelter G, Imhoff JF, Müller R, Paululat T. Synthesis and Cytotoxic Activity of a Small Naphthoquinone Library: First Synthesis of Juglonbutin: First Synthesis of Juglonbutin. Eur J Org Chem 2014;2014:5318-30. [DOI: 10.1002/ejoc.201402272] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
292 Jantová S, Letašiová S, Repický A, Ovádeková R, Lakatoš B. The effect of 3-(5-nitro-2-thienyl)-9-chloro-5-morpholin-4-yl[1,2,4]triazolo[4,3-c]quinazoline on cell growth, cell cycle, induction of DNA fragmentation, and activity of caspase 3 in murine leukemia L1210 cells and fibroblast NIH-3T3 cells. Cell Biochem Funct 2006;24:519-30. [DOI: 10.1002/cbf.1296] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
293 Greay SJ, Ireland DJ, Kissick HT, Levy A, Beilharz MW, Riley TV, Carson CF. Induction of necrosis and cell cycle arrest in murine cancer cell lines by Melaleuca alternifolia (tea tree) oil and terpinen-4-ol. Cancer Chemother Pharmacol 2010;65:877-88. [PMID: 19680653 DOI: 10.1007/s00280-009-1093-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
294 Sundaram MK, Raina R, Afroze N, Dhupkar A, Kaur NP, Arte A, Khan FA, Hussain A. Combinational Use of Phytochemicals and Chemotherapeutic Drugs Enhance Their Therapeutic Potential on Human Cervical Cancer Cells. Int J Cancer Manag 2019;12. [DOI: 10.5812/ijcm.91783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
295 Kolokotroni E, Dionysiou D, Veith C, Kim YJ, Sabczynski J, Franz A, Grgic A, Palm J, Bohle RM, Stamatakos G. In Silico Oncology: Quantification of the In Vivo Antitumor Efficacy of Cisplatin-Based Doublet Therapy in Non-Small Cell Lung Cancer (NSCLC) through a Multiscale Mechanistic Model. PLoS Comput Biol 2016;12:e1005093. [PMID: 27657742 DOI: 10.1371/journal.pcbi.1005093] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
296 Hickman JA. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 1992;11:121-139. [PMID: 1327566 DOI: 10.1007/BF00048059] [Cited by in Crossref: 571] [Cited by in F6Publishing: 136] [Article Influence: 19.7] [Reference Citation Analysis]
297 Collins MK, Marvel J, Malde P, Lopez-Rivas A. Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J Exp Med 1992;176:1043-51. [PMID: 1402650 DOI: 10.1084/jem.176.4.1043] [Cited by in Crossref: 148] [Cited by in F6Publishing: 151] [Article Influence: 5.1] [Reference Citation Analysis]
298 Fox ME, Feldman BJ, Chu G. A novel role for DNA photolyase: binding to DNA damaged by drugs is associated with enhanced cytotoxicity in Saccharomyces cerevisiae. Mol Cell Biol 1994;14:8071-7. [PMID: 7969145 DOI: 10.1128/mcb.14.12.8071-8077.1994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 0.0] [Reference Citation Analysis]
299 Mca'nulty MM, Lippard SJ. The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast. Mutation Research/DNA Repair 1996;362:75-86. [DOI: 10.1016/0921-8777(95)00037-2] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 2.9] [Reference Citation Analysis]
300 Jamieson ER, Lippard SJ. Structure, Recognition, and Processing of Cisplatin-DNA Adducts. Chem Rev. 1999;99:2467-2498. [PMID: 11749487 DOI: 10.1021/cr980421n] [Cited by in Crossref: 2131] [Cited by in F6Publishing: 1995] [Article Influence: 96.9] [Reference Citation Analysis]
301 Livingstone A, Mairs RJ. N-myc amplification and its relationship to experimental therapy. J Neurooncol 1997;31:33-9. [PMID: 9049828 DOI: 10.1023/a:1005773011779] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
302 da Silva CP, de Oliveira CR, de Lima MDCP. Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukemic T-lymphocytes. Biochemical Pharmacology 1996;51:1331-40. [DOI: 10.1016/0006-2952(96)00041-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]